Name | Relevance to the topic |
---|---|
Campbell, Jean | Founding member of Professional Patient Advocates in Life Sciences, a non-profit organization in the United States to support patient-advocacy professionals in pharmaceutical and biotechnology companies. |
Greene, Lesley | Founder of Children Living with Inherited Metabolic Diseases (CLIMB), founding member of EURORDIS, and currently a patient-representative member (2009-) and vice chair of COMP (2012-). |
Hayden, Cori | Professor of Anthropology at the University of California Berkeley, with research interest in benefit-sharing arrangements in biosciences. |
Kent, Alastair | Director of Genetic Alliance UK and chair of Rare Diseases UK, which is a multi-stakeholder campaign in the United Kingdom for patients with rare diseases and all who support them. |
Livingston, Heidi | Public Involvement Advisor at the National Institute for Health and Clinical Excellence (NICE) (participated in a personal capacity as an expert in patient involvement in technology appraisal processes). |
Meadowcroft, Robert | Chief executive of Muscular Dystrophy UK, a charity organization supporting individuals affected by muscle-waisting conditions in the United Kingdom. |
Mikami, Koichi | Research fellow in Making Genomic Medicine at the University of Edinburgh and co-organizer of the workshop. |
Moreira, Tiago | Reader at Durham University with research interest in the roles of patient organizations in the organization of health care and governance of biomedicine. |
Parker, Samantha | Head of Patient and Policy Affairs at biotechnology company Lysogene in France. |
Pavelin, Colin | Head of Regenerative Medicine and Rare Disease Policy at the UK Department of Health (participating in a personal capacity as an expert in national policies on rare diseases in the UK). |
Purves, John | Former head of the Quality of Medicines sector at the European Medicines Agency, and an honorary fellow of the Innogen Centre at the University of Edinburgh. |
Roberts, Charlotte | Communications Officer of the MPS Society, a charitable organization supporting individuals, families and professionals affected by mucopolysaccharide and related diseases throughout the United Kingdom. |
Schoneveld van der Linde, Maryze | Former board member of the International Pompe Association, and a founder of consultant company Patient Centered Solutions in the Netherlands. |
Spink, Jayne | Chief Executive Officer of the Tuberous Sclerosis Association, a charity supporting individuals affected by tuberous sclerosis complex and their families and carers in the United Kingdom and funding research. |
Spring, Rachel | Theme Coordinator at the National Institute for Health Research’s Rare Diseases Translational Research Collaboration |
Sturdy, Steve | Professor of the Sociology of Medical Knowledge at the University of Edinburgh, principal investigator of the Making Genomic Medicine project, and co-organizer of the workshop. |
Timmis, Oliver | Chief Executive Officer of the AKU Society, a charity organization supporting individuals affected by alkaptonuria in the United Kingdom that initiated a EU-funded consortium called DevelopAKUre program. |
Upadhyaya, Sheela | Associate Director of Highly Specialised Technology program at the National Institute for Health and Clinical Excellence (participated in personal capacity as an expert in evaluation of medicines for rare diseases). |